[HIV Restriction Factor APOBEC3G and Prospects for Its Use in Gene Therapy for HIV].
Mol Biol (Mosk)
; 56(4): 546-556, 2022.
Article
em Ru
| MEDLINE
| ID: mdl-35964311
ABSTRACT
The mechanisms for the protection of the human body from viral or bacterial agents are extremely diverse. In one such mechanism, an important role belongs to the cytidine deaminase APOBEC3 family, which is the factor of congenital immunity and protects the organism from numerous viral agents. One of the proteins of this family, APOBEC3G, is able to protect against Human Immunodeficiency Virus type 1 in the absence of viral protein Vif. In turn, Vif opposes APOBEC3G action, causing polyubiquity of the protein and degradation in the proteasome. The review describes possible ways to increase the anti-HIV activity of APOBEC3G, giving it resistance to viral protein Vif, as well as potential approaches to the use of modified APOBEC3G in gene therapy for HIV.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
HIV-1
/
Produtos do Gene vif do Vírus da Imunodeficiência Humana
Limite:
Humans
Idioma:
Ru
Revista:
Mol Biol (Mosk)
Ano de publicação:
2022
Tipo de documento:
Article